geen specifieke aandoening te benoemen. de ontwikkelde protocollen en beeldverwerkingstechnieken kunnen voor verschillende aandoeningen worden gebruikt. Protocol development
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - >= 18 years - Capable and prepared to sign an informed consent
Exclusion criteria
Exclusion criteria: - Contraindication for MRI scanning as listed in the MRI screening form, according to the current MR safety guidelines - Neurological or psychiatric diagnosis - (possible) pregnancy -Refusal of subjects to be informed of chance findings possibly relevant to their health In the event that the RespirAct system is used for a sub-study: - Unwilling or unable to cooperate with breathing protocol or keeping still; - Medical contraindications to limited hypercapnia (known metabolic acidosis or alkalosis); - Standard contraindications for using the RespirAct RA-MRTM MRI UNIT (see D2 IMDD 2.5 contraindications); - Known cerebrovascular, cardiovascular or pulmonary (or other) disease - concurrent severe or uncontrolled medical disease (e.g., active systemic infection);
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The development and optimization of new and existing MRI protocols and processing techniques required for anatomical and functional imaging in the research and clinical setting. In addition new methods will be developed for image processing. | — |
Secondary
| Measure | Time frame |
|---|---|
| Not applicable. | — |
Countries
Netherlands